By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Affymetrix reported after the close of the market Wednesday that its third-quarter revenues dropped around 14 percent year over year on lower product sales.

The Santa Clara, Calif.-based microarray technologies firm also said that it has reorganized its business into three new business units.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.